| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 4e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |